CRNX NASDAQ
Crinetics Pharmaceuticals, Inc.
1W: -3.2%
1M: -5.1%
3M: -14.6%
YTD: -20.6%
1Y: +18.2%
3Y: +67.8%
5Y: +128.7%
$36.80
-0.29 (-0.78%)
Weekly Expected Move ±8.8%
$30
$34
$37
$40
$43
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026284
Institutions Holding
+6 vs prior
98.1%
Ownership
-27.83%
40
New
106
Increased
115
Reduced
64
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | Knight Jeff E. | officer: chief dev. & operating officer | S-Sale | 85,163 | $40.10 | $3.4M | Filing |
| 2026-03-12 | Vivaldi Coelho Rogerio | director | S-Sale | 523 | $36.77 | $19K | Filing |
| 2026-03-12 | Vivaldi Coelho Rogerio | director | S-Sale | 4,477 | $36.08 | $162K | Filing |
| 2026-03-03 | Okey Stephanie | director | S-Sale | 3,000 | $39.67 | $119K | Filing |
| 2026-03-03 | Schilke Tobin | officer: chief financial officer | S-Sale | 6,713 | $39.67 | $266K | Filing |
| 2026-02-23 | Struthers Richard Scott | officer: president & ceo | A-Grant/Award | 62,000 | $— | $0 | Filing |
| 2026-02-23 | Schilke Tobin | officer: chief financial officer | A-Grant/Award | 32,000 | $— | $0 | Filing |
| 2026-02-23 | Knight Jeff E. | officer: chief operating officer | A-Grant/Award | 34,000 | $— | $0 | Filing |
| 2026-02-23 | Kalofonos Isabel | officer: chief commercial officer | A-Grant/Award | 34,000 | $— | $0 | Filing |
| 2026-02-23 | Betz Stephen F. | officer: chief scientific officer | A-Grant/Award | 30,000 | $— | $0 | Filing |
| 2026-01-05 | Kalofonos Isabel | officer: chief commercial officer | S-Sale | 2,500 | $55.00 | $138K | Filing |
| 2025-12-01 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 5,000 | $45.02 | $225K | Filing |
| 2025-11-03 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 100 | $43.27 | $4K | Filing |
| 2025-11-03 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 4,900 | $42.65 | $209K | Filing |
| 2025-10-01 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 5,000 | $41.81 | $209K | Filing |
| 2025-09-26 | Struthers Richard Scott | officer: president & ceo | S-Sale | 4,000 | $45.00 | $180K | Filing |
| 2025-09-26 | Fust Matthew K | director | S-Sale | 16,000 | $44.75 | $716K | Filing |
| 2025-09-02 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 5,000 | $32.10 | $160K | Filing |
| 2025-08-22 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 30,000 | $30.43 | $913K | Filing |
| 2025-08-20 | Pizzuti Dana | officer: chief med and dev officer | S-Sale | 6,492 | $29.18 | $189K | Filing |
| 2025-06-12 | Betz Stephen F. | officer: chief scientific officer | S-Sale | 97,483 | $32.23 | $3.1M | Filing |
| 2025-06-11 | Okey Stephanie | director | A-Grant/Award | 6,900 | $— | $0 | Filing |
| 2025-06-11 | Deardorf Caren | director | A-Grant/Award | 6,900 | $— | $0 | Filing |
| 2025-06-11 | Vivaldi Coelho Rogerio | director | A-Grant/Award | 6,900 | $— | $0 | Filing |
| 2025-06-11 | Bedrosian Camille L | director | A-Grant/Award | 6,900 | $— | $0 | Filing |
🏛️ Congressional Trades
1 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2024-09-25 | Josh Gottheimer | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 15,759,799 | $572M | +1,466,024 | 2026-03-31 | Filing |
| BlackRock, Inc. | 8,478,815 | $308M | +490,267 | 2026-03-31 | Filing |
| FARALLON CAPITAL MANAGEMENT LLC | 8,338,098 | $303M | +1,405,000 | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 8,157,204 | $296M | +119,315 | 2026-03-31 | Filing |
| Driehaus Capital Management LLC | 6,395,922 | $232M | +8,182 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,673,935 | $170M | +4,673,935 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,638,511 | $168M | +4,638,511 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 4,520,251 | $164M | +79,560 | 2026-03-31 | Filing |
| EcoR1 Capital, LLC | 4,288,120 | $156M | — | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,480,763 | $90M | +238,132 | 2026-03-31 | Filing |
| STATE STREET CORP | 2,403,046 | $87M | +241,668 | 2026-03-31 | Filing |
| Siren, L.L.C. | 1,903,636 | $69M | +396,000 | 2026-03-31 | Filing |
| Pictet Asset Management Holding SA | 1,884,281 | $68M | +323,981 | 2026-03-31 | Filing |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A | 1,716,445 | $62M | +389,063 | 2026-03-31 | Filing |
| GW&K Investment Management, LLC | 1,618,686 | $59M | +142,361 | 2026-03-31 | Filing |
| RTW INVESTMENTS, LP | 1,451,326 | $53M | +100,000 | 2026-03-31 | Filing |
| JPMORGAN CHASE & CO | 1,324,668 | $45M | +169,958 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 1,139,331 | $41M | +829,963 | 2026-03-31 | Filing |
| First Light Asset Management, LLC | 1,089,670 | $40M | -104,593 | 2026-03-31 | Filing |
| AMERICAN CENTURY COMPANIES INC | 1,052,858 | $38M | -16,020 | 2026-03-31 | Filing |